StreetInsider.com News Articles

Form 4 KESTRA MEDICAL TECHNOLOG For: Jul 15 Filed by: Ford Alfred J Jr

Fri, 17 Jul 2026 17:52:00 -0400

si-local-file:///var/storage/secattach/20260717/26785328.html

Form 4 KESTRA MEDICAL TECHNOLOG For: Jul 15 Filed by: Ford Alfred J Jr

Fri, 17 Jul 2026 17:52:00 -0400

si-local-file:///var/storage/secattach/20260717/26785328.html

Form 4 KESTRA MEDICAL TECHNOLOG For: Jul 15 Filed by: Moran Timothy P.

Fri, 17 Jul 2026 17:52:00 -0400

si-local-file:///var/storage/secattach/20260717/26785330.html

Form 4 KESTRA MEDICAL TECHNOLOG For: Jul 15 Filed by: Moran Timothy P.

Fri, 17 Jul 2026 17:52:00 -0400

si-local-file:///var/storage/secattach/20260717/26785330.html

Form 4 KESTRA MEDICAL TECHNOLOG For: Jul 15 Filed by: Mahboob Vaseem

Fri, 17 Jul 2026 17:51:00 -0400

si-local-file:///var/storage/secattach/20260717/26785325.html

Form 4 KESTRA MEDICAL TECHNOLOG For: Jul 15 Filed by: Mahboob Vaseem

Fri, 17 Jul 2026 17:51:00 -0400

si-local-file:///var/storage/secattach/20260717/26785325.html

Form 4 KESTRA MEDICAL TECHNOLOG For: Jul 15 Filed by: Umberger Traci S

Fri, 17 Jul 2026 17:50:00 -0400

si-local-file:///var/storage/secattach/20260717/26785321.html

Form 4 KESTRA MEDICAL TECHNOLOG For: Jul 15 Filed by: Umberger Traci S

Fri, 17 Jul 2026 17:50:00 -0400

si-local-file:///var/storage/secattach/20260717/26785321.html

Form 4 KESTRA MEDICAL TECHNOLOG For: Jul 15 Filed by: Webster Brian Daniel

Fri, 17 Jul 2026 17:49:00 -0400

si-local-file:///var/storage/secattach/20260717/26785319.html

Form 4 KESTRA MEDICAL TECHNOLOG For: Jul 15 Filed by: Webster Brian Daniel

Fri, 17 Jul 2026 17:49:00 -0400

si-local-file:///var/storage/secattach/20260717/26785319.html

Form 144 KESTRA MEDICAL TECHNOLOG Filed by: Webster Brian Daniel

Wed, 15 Jul 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260715/26774391.html

Form 144 KESTRA MEDICAL TECHNOLOG Filed by: Webster Brian Daniel

Wed, 15 Jul 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260715/26774391.html

Kestra Medical Technologies (KMTS) Reiterated at Buy by Stifel on Above-Average Growth

Wed, 15 Jul 2026 07:25:01 -0400

Stifel analyst Rick Wise reiterated a Buy rating and $30.00 price target on Kestra Medical Technologies (NASDAQ: KMTS).

The analyst commented, "Impressively, Kestra closed out fiscal year 2026 (April) with yet another quarter of well-above average growth. In F4Q26, KMTS reported total revenue of $28.6M (up +66% y/y) that nicely exceeded our/ consensus $26.5M estimate. Management noted F4Q26 was the largest sequential Q/Q sales step-up of the year, driven by record ASSURE wearable cardioverterdefibrillator ("WCD") prescriptions (growth accelerated to +63%), continued marketshare gains, and revenue-cycle management improvements. Across the P&L the company turned in better than expected performance. Gross margin reached

Kestra Medical Technologies (KMTS) PT Raised to $30 at Wolfe Research

Wed, 15 Jul 2026 05:33:47 -0400

Wolfe Research analyst Mike Polark raised the price target on Kestra Medical Technologies (NASDAQ: KMTS) to $30.00 (from $29.00) while maintaining a Outperform rating.

The analyst comments "Crisp execution continues – scripts even surprised internal model in quarter. New FY27 guide seems comfy – original FY26 revenue beaten by 12%. Zoll under warning letter for non-WCD products; maybe nothing but not good – small destabilizer for the competitor = opportunity?"

Kestra Medical Technologies (KMTS) PT Raised to $30 at Wolfe Research

Wed, 15 Jul 2026 05:33:47 -0400

Wolfe Research analyst Mike Polark raised the price target on Kestra Medical Technologies (NASDAQ: KMTS) to $30.00 (from $29.00) while maintaining a Outperform rating.

Form 10-K KESTRA MEDICAL TECHNOLOG For: Apr 30

Tue, 14 Jul 2026 17:17:00 -0400

si-local-file:///var/storage/secattach/20260714/26769075.html

Form 10-K KESTRA MEDICAL TECHNOLOG For: Apr 30

Tue, 14 Jul 2026 17:17:00 -0400

si-local-file:///var/storage/secattach/20260714/26769075.html

Form 8-K KESTRA MEDICAL TECHNOLOG For: Jul 10

Tue, 14 Jul 2026 16:09:00 -0400

si-local-file:///var/storage/secattach/20260714/26768331.html

Form 8-K KESTRA MEDICAL TECHNOLOG For: Jul 10

Tue, 14 Jul 2026 16:09:00 -0400

si-local-file:///var/storage/secattach/20260714/26768331.html

Kestra Medical secures $200M term loan facility with Pharmakon

Tue, 14 Jul 2026 16:06:40 -0400

Kestra Medical Technologies (Nasdaq: KMTS) has entered into a five-year term loan facility with funds managed by Pharmakon Advisors, LP, providing up to $200 million in non-dilutive financing, according to a press release issued July 14, 2026.

The financing is structured in four tranches. A $75 million tranche was funded at closing, part of which retired Kestra's existing $45 million term loan and covered fees and expenses. A $25 million tranche is available at Kestra's option through July 2027. A $50 million tranche is available through June 2028, contingent on the company generating $150 million in trailing 12-month revenue. An additional

Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing

Tue, 14 Jul 2026 16:05:00 -0400

KIRKLAND, Wash., July 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced that it has entered into a five-year term loan facility with funds managed by Pharmakon Advisors, LP.

The non-dilutive financing consists of:

$75 million tranche funded at closing, a portion of which was used to retire Kestra’s existing $45 million term loan and pay fees and expenses.
$25 million tranche available at Kestra’s option through July 2027.
$50 million tranche available at Kestra’s option

Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing

Tue, 14 Jul 2026 16:05:00 -0400

The non-dilutive financing consists of:

$75 million tranche funded at closing, a portion of which was used to retire Kestra’s existing $45 million term loan and pay fees and expenses.
$25 million tranche available at Kestra’s option through July 2027.
$50 million tranche available at Kestra’s option

Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing

Tue, 14 Jul 2026 16:05:00 -0400

The non-dilutive financing consists of:

$75 million tranche funded at closing, a portion of which was used to retire Kestra’s existing $45 million term loan and pay fees and expenses.
$25 million tranche available at Kestra’s option through July 2027.
$50 million tranche available at Kestra’s option

Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing

Tue, 14 Jul 2026 16:05:00 -0400

The non-dilutive financing consists of:

$75 million tranche funded at closing, a portion of which was used to retire Kestra’s existing $45 million term loan and pay fees and expenses.
$25 million tranche available at Kestra’s option through July 2027.
$50 million tranche available at Kestra’s option

Kestra Medical Technologies, Ltd. (KMTS) Misses Q2 EPS by 9c, Beats on Revenue

Tue, 14 Jul 2026 16:03:32 -0400

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) reported Q2 EPS of ($0.67), $0.09 worse than the analyst estimate of ($0.58). Revenue for the quarter came in at $28.64 million, versus $26.5 million reported last year.

For earnings history and earnings-related data on Kestra Medical Technologies, Ltd. (KMTS) click here.